BioMarin Pharmaceuticals
BMRN
BMRN
388 hedge funds and large institutions have $16.9B invested in BioMarin Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 150 increasing their positions, 141 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 393 → 388 (-5)
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Holders
388
Holding in Top 10
9
Calls
$249M
Puts
$199M
Top Buyers
| 1 | +$182M | |
| 2 | +$166M | |
| 3 | +$104M | |
| 4 |
Temasek Holdings
Singapore
|
+$93.1M |
| 5 |
Goldman Sachs
New York
|
+$70.3M |
Top Sellers
| 1 | -$207M | |
| 2 | -$99.7M | |
| 3 | -$48.2M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$38.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37M |